EQUIBAN GRANULES

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
MORANTEL TARTRATE
Available from:
ZOETIS AUSTRALIA PTY LTD
INN (International Name):
morantel tartate(115mg/g)
Pharmaceutical form:
ORAL GRANULES, PELLETS
Composition:
MORANTEL TARTRATE ANTHELMINTIC Active 115.0 mg/g
Units in package:
24g
Class:
VP - Veterinary Pesticide
Manufactured by:
ZOETIS AUSTRALIA
Therapeutic group:
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
Therapeutic area:
PARASITICIDES
Therapeutic indications:
LARGE ROUNDWORM - PARASCARIS EQUORUM | LARGE STRONGYLES - STRONGYLUS SPP. | PINWORM - OXYURIS EQUI | SMALL STRONGYLE-LUMEN DWELLING IMMATURE | SMALL STRONGYLES - CYATHOSTOMUM SPP. | STRONGYLUS VULGARIS - IMMATURE | TAPEWORM - ANOPLOCEPHALA PERFOLIATA | TRIODONTOPHORUS SPP. - IMMATURE | BLOODWORM | LARGE WHITE ROUNDWORM | RED WORM | REDWORM | STRONGYLE | TAPEWORM - HORSE
Product summary:
Poison schedule: 0; Withholding period: WHP: MEAT - DO NOT USE LESS THAN 28 DAY S BEFORE SLAUGHTER FOR HUMAN CONSUMPTIO N.; Host/pest details: HORSE: [LARGE ROUNDWORM - PARASCARIS EQUORUM, LARGE STRONGYLES - STRONGYLUS SPP., PINWORM - OXYURIS EQUI, SMALL STRONGYLE-LUMEN DWELLING IMMATURE, SMALL STRONGYLES - CYATHOSTOMUM SPP., STRONGYLUS VULGARIS - IMMATURE, TAPEWORM - ANOPLOCEPHALA PERFOLIATA, TRIODONTOPHORUS SPP. - IMMATURE]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE: [LARGE ROUNDWORM - PARASCARIS EQUORUM, LARGE STRONGYLES - STRONGYLUS SPP., PINWORM - OXYURIS EQUI, SMALL STRONGYLE-LUMEN DWELLING IMMATURE, SMALL STRONGYLES - CYATHOSTOMUM SPP., STRONGYLUS VULGARIS - IMMATURE, TAPEWORM - ANOPLOCEPHALA PERFOLIATA, TRIODONTOPHORUS SPP. - IMMATURE]; For the control of large strongyles, small strongyles, large roundworm and pinworm in horses. Good activity has been also demonstrated against tapeworm, and lumen dwelling immature forShould not be administered by stomach tube. Do not treat foals less than 1 week of age.
Authorization status:
Registered
Authorization number:
49805
Authorization date:
2020-07-01

DRAFT SACHET FRONT

ANIMAL

TREATMENT

ONLY

Equiban*

Granules

(horse

head

logo)

Morantel

tartrate 115

mglg

Aniseed flavoured broad spectrum Horse Wormer

for the control

large strongyles

(Strongylus

spp.),

small

strongyles (Cyathostomes),

large

roundworm

(Parascaris equorum)

and pinworm (Oxyuris

equi)

in horses.

Good activity has

also been demonstrated against tapeworm

(Anoplocephala perfoliata)

and lumen dwelling

immature forms of

Cyathostomum

spp ..

Ttiodontoonorus

spp.

Strongylus vulgaris.

24 9 NET

Pfizer

(logo)

SACHET

Back Panel

DIRECTIONS

USE:

This

product

should

be administered by stomach tube.

treat

foals

than one week

age.

Dose:

One sachet EOUIBAN GRANULES per

kg bodyweight (10 mglkg morantel

tartrate).

The following table is a gUide only to bodyweights of horses as individual

animals

vary

considerably.

If there is doubt, weigh the horse accurately before dosing.

COMMON

EQUIBAN

DOSE

TYPE OF HORSE

BODYWEIGHT

GRANULES

SACHET

Hunter

650 kg

Hack

Yearling

Shetland Pony

Foal

EOUIBAN GRANULES are safe to use in pregnant mares. foals over one

week

debilitated animals.

Treatment should be carried out

every

weeks throughout the year.

EQUIBAN GRANULES are compatible with Neguvon (Bayer) and carbon disulphide at

recommended dose levels for

Gasterophilus

(bot) control.

Administration:

EQUIBAN GRANULES are formulated in a palatable aniseed flavoured

base for adding to the feed.

Add the required dose to a small

amount

feed.

MEAT WITHHOLDING PERIOD:

DO NOT use less

than

28 days before

slaughter

human

consumption

NRA:

49805/01

Store below

30·C

(Room Temperature)

Exp.

(Pfizer logo)

PM No.

Made in Australia

Animal

Health

A division of Pfizer

Limited

Wharf Road, West Ryde, NSW 2114

Product Name: Equiban Granules

Page: 1 of 4

This revision issued: August, 2011

MATERIAL SAFETY DATA SHEET

Issued by: Pfizer Australia Pty Ltd

Phone: 1800 814 883

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

Section 1 - Identification of The Material and Supplier

Pfizer Australia Pty Ltd

38-42 Wharf Road

West Ryde NSW 2114

Tel: 1800 814 883

Fax: (02) 9850 3399

____________________________________

Pfizer Australia Pty Ltd

A.B.N. 50 008 422 348

Chemical nature:

Blend of ingredients. Active ingredient is an anthelmintic.

Trade Name:

Equiban Granules

Product Use:

Control of roundworms, bloodworms, redworms and pinworms in horses.

Creation Date:

September, 2006

This version issued:

August, 2011

and is valid for 5 years from this date.

Section 2 - Hazards Identification

Statement of Hazardous Nature

This product is classified as:

Not classified as hazardous according to the criteria of SWA.

Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.

Risk Phrases:

Not Hazardous - No criteria found.

Safety Phrases:

S45. In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre

immediately (show the label where possible).

SUSMP Classification:

None allocated.

ADG Classification:

None allocated. Not a Dangerous Good under the ADG Code.

UN Number:

None allocated

E

E

E

m

m

m

e

e

e

r

r

r

g

g

g

e

e

e

n

n

n

c

c

c

y

y

y

O

O

O

v

v

v

e

e

e

r

r

r

v

v

v

i

i

i

e

e

e

w

w

w

Physical Description & colour

: Pale yellow granules.

Odour:

Aniseed odour.

Major Health Hazards:

no significant risk factors have been found for this product.

P

P

P

o

o

o

t

t

t

e

e

e

n

n

n

t

t

t

i

i

i

a

a

a

l

l

l

H

H

H

e

e

e

a

a

a

l

l

l

t

t

t

h

h

h

E

E

E

f

f

f

f

f

f

e

e

e

c

c

c

t

t

t

s

s

s

Inhalation:

Short term exposure:

Long term inhalation of high amounts of any nuisance dust may overload lung clearance

mechanism. Available data indicates that this product is not harmful. In addition product is unlikely to cause any

discomfort or irritation.

Long Term exposure:

No data for health effects associated with long term inhalation.

Skin Contact:

Short term exposure:

Available data indicates that this product is not harmful. It should present no hazards in

normal use. However product may be mildly irritating, but is unlikely to cause anything more than mild discomfort

which should disappear once contact ceases.

Long Term exposure:

No data for health effects associated with long term skin exposure.

Eye Contact:

Short term exposure

: This product may be mildly irritating to eyes, but is unlikely to cause anything more than

mild discomfort which should disappear once product is removed.

Long Term exposure

: No data for health effects associated with long term eye exposure.

Ingestion:

Short term exposure

: Significant oral exposure is considered to be unlikely. However, this product may be

irritating to mucous membranes but is unlikely to cause anything more than transient discomfort.

Long Term exposure

: No data for health effects associated with long term ingestion.

Carcinogen Status:

SWA:

No significant ingredient is classified as carcinogenic by SWA.

NTP:

No significant ingredient is classified as carcinogenic by NTP.

Product Name: Equiban Granules

Page: 2 of 4

This revision issued: August, 2011

MATERIAL SAFETY DATA SHEET

Issued by: Pfizer Australia Pty Ltd

Phone: 1800 814 883

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

IARC:

No significant ingredient is classified as carcinogenic by IARC.

Section 3 - Composition/Information on Ingredients

Ingredients

CAS No

Conc,%

TWA (mg/m

STEL (mg/m

Morantel tartrate

26155-31-7

10-20

not set

not set

Other non hazardous ingredients

secret

to 100

not set

not set

This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non

hazardous ingredients are also possible.

The SWA TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day

for a 5 day working week. The STEL (Short Term Exposure Limit) is an exposure value that may be equalled (but should not be exceeded) for no

longer than 15 minutes and should not be repeated more than 4 times per day. There should be at least 60 minutes between successive exposures

at the STEL. The term "peak "is used when the TWA limit, because of the rapid action of the substance, should never be exceeded, even briefly.

Section 4 - First Aid Measures

General Information:

You should call The Poisons Information Centre if you feel that you may have been poisoned, burned or irritated by

this product. The number is 13 1126 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all

times. Have this MSDS with you when you call.

Inhalation:

First aid is not generally required. If in doubt, contact a Poisons Information Centre or a doctor.

Skin Contact:

Gently brush away excess solids. Irritation is unlikely. However, if irritation does occur, flush with

lukewarm, gently flowing water for 5 minutes or until chemical is removed.

Eye Contact:

Quickly and gently brush particles from eyes. No effects expected. If irritation does occur, flush

contaminated eye(s) with lukewarm, gently flowing water for 5 minutes or until the product is removed. Obtain medical

advice if irritation becomes painful or lasts more than a few minutes. Take special care if exposed person is wearing

contact lenses.

Ingestion:

If product is swallowed or gets in mouth, do NOT induce vomiting; wash mouth with water and give some

water to drink. If symptoms develop, or if in doubt contact a Poisons Information Centre or a doctor.

Section 5 - Fire Fighting Measures

Fire and Explosion Hazards

: There is no risk of an explosion from this product under normal circumstances if it is

involved in a fire.

Fire decomposition products from this product may be toxic if inhaled. Take appropriate protective measures.

Extinguishing Media

: Preferred extinguishing media are carbon dioxide, dry chemical, foam, water fog.

Fire Fighting

: If a significant quantity of this product is involved in a fire, call the fire brigade.

Flash point

:

Not flammable.

Upper Flammability Limit:

No data.

Lower Flammability Limit:

No data.

Autoignition temperature:

No data.

Flammability Class:

No data.

Section 6 - Accidental Release Measures

Accidental release

: Minor spills do not normally need any special cleanup measures. In the event of a major spill,

prevent spillage from entering drains or water courses. As a minimum, wear overalls, goggles and gloves. Suitable

materials for protective clothing include rubber, PVC. Eye/face protective equipment should comprise as a minimum,

protective glasses and, preferably, goggles. If there is a significant chance that dusts are likely to build up in cleanup

area, we recommend that you use a suitable Dust Mask.

Stop leak if safe to do so, and contain spill. Sweep up and shovel or collect recoverable product into labelled

containers for recycling or salvage, and dispose of promptly. Consider vacuuming if appropriate. Recycle containers

wherever possible after careful cleaning. After spills, wash area preventing runoff from entering drains. If a significant

quantity of material enters drains, advise emergency services. This material may be suitable for approved landfill.

Ensure legality of disposal by consulting regulations prior to disposal. Thoroughly launder protective clothing before

storage or re-use. Advise laundry of nature of contamination when sending contaminated clothing to laundry.

Section 7 - Handling and Storage

Handling

: Keep exposure to this product to a minimum, and minimise the quantities kept in work areas. Check

Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed.

The measures detailed below under "Storage" should be followed during handling in order to minimise risks to

Product Name: Equiban Granules

Page: 3 of 4

This revision issued: August, 2011

MATERIAL SAFETY DATA SHEET

Issued by: Pfizer Australia Pty Ltd

Phone: 1800 814 883

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

persons using the product in the workplace. Also, avoid contact or contamination of product with incompatible

materials listed in Section 10.

Storage

: Store packages of this product in a cool place. Make sure that containers of this product are kept tightly

closed. Keep containers dry and away from water. Keep containers of this product in a well ventilated area. Make

sure that the product does not come into contact with substances listed under "Incompatibilities" in Section 10. Check

packaging - there may be further storage instructions on the label.

Section 8 - Exposure Controls and Personal Protection

The following Australian Standards will provide general advice regarding safety clothing and equipment:

Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Occupational Protective Clothing: AS/NZS 4501

set 2008, Industrial Eye Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210.

SWA Exposure Limits

TWA (mg/m

3

)

STEL (mg/m

3

)

Exposure limits have not been established by SWA for any of the significant ingredients in this product.

No special equipment is usually needed when occasionally handling small quantities. The following instructions are

for bulk handling or where regular exposure in an occupational setting occurs without proper containment systems.

Ventilation:

No special ventilation requirements are normally necessary for this product. However make sure that

the work environment remains clean and that dusts are minimised.

Eye Protection:

Eye protection is not normally necessary when this product is being used. However, if in doubt,

wear suitable protective glasses or goggles.

Skin Protection:

The information at hand indicates that this product is not harmful and that normally no special skin

protection is necessary. However, we suggest that you routinely avoid contact with all chemical products and that you

wear suitable gloves (preferably elbow-length) when skin contact is likely.

Protective Material Types:

There is no specific recommendation for any particular protective material type.

Respirator:

Usually, no respirator is necessary when using this product. However, if you have any doubts consult

the Australian Standard mentioned above.

Section 9 - Physical and Chemical Properties:

Physical Description & colour

Pale yellow granules.

Odour:

Aniseed odour.

Boiling Point:

Not applicable.

Freezing/Melting Point:

Decomposes before melting.

Volatiles:

No specific data. Expected to be low at 100°C.

Vapour Pressure:

No data.

Vapour Density:

No data.

Specific Gravity:

No data.

Water Solubility:

Soluble.

pH:

No data.

Volatility:

No data.

Odour Threshold:

No data.

Evaporation Rate:

No data.

Coeff Oil/water distribution

No data

Autoignition temp:

No data.

Section 10 - Stability and Reactivity

Reactivity:

This product is unlikely to react or decompose under normal storage conditions. However, if you have

any doubts, contact the supplier for advice on shelf life properties.

Conditions to Avoid:

This product should be kept in a cool place, preferably below 30°C. Keep containers tightly

closed. Containers should be kept dry. Keep containers and surrounding areas well ventilated.

Incompatibilities:

strong acids, strong bases, strong oxidising agents.

Fire Decomposition:

Carbon dioxide, and if combustion is incomplete, carbon monoxide and smoke. Oxides of

sulfur (sulfur dioxide is a respiratory hazard) and other sulfur compounds. Most will have a foul odour. Water. Carbon

monoxide poisoning produces headache, weakness, nausea, dizziness, confusion, dimness of vision, disturbance of

judgment, and unconsciousness followed by coma and death.

Polymerisation:

This product will not undergo polymerisation reactions.

Section 11 - Toxicological Information

Target Organs:

none known

Product Name: Equiban Granules

Page: 4 of 4

This revision issued: August, 2011

MATERIAL SAFETY DATA SHEET

Issued by: Pfizer Australia Pty Ltd

Phone: 1800 814 883

Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)

C

C

C

l

l

l

a

a

a

s

s

s

s

s

s

i

i

i

f

f

f

i

i

i

c

c

c

a

a

a

t

t

t

i

i

i

o

o

o

n

n

n

o

o

o

f

f

f

H

H

H

a

a

a

z

z

z

a

a

a

r

r

r

d

d

d

o

o

o

u

u

u

s

s

s

I

I

I

n

n

n

g

g

g

r

r

r

e

e

e

d

d

d

i

i

i

e

e

e

n

n

n

t

t

t

s

s

s

Ingredient

Risk Phrases

No ingredient mentioned in the HSIS Database is present in this product at hazardous concentrations.

The LD

(Oral) values for morantel tartrate are 179-260mg/kg for mice and 551-586mg/kg for rats. The main

symptoms of intoxication are respiratory effects, hypothermia, ataxia, tremors and convulsions.

No evidence has been found for carcinogenicity, mutagenicity, reproductive effects or sensitisation.

Section 12 - Ecological Information

Insufficient data to be sure of status.

Section 13 - Disposal Considerations

Disposal:

There are many pieces of legislation covering waste disposal and they differ in each state and territory, so

each user must refer to laws operating in their area. In some areas, certain wastes must be tracked. The Hierarchy of

Controls seems to be common - the user should investigate: Reduce, Reuse, and Recycle and only if all else fails

should disposal be considered. Note that properties of a product may change in use, so that the following suggestions

may not always be appropriate. The following may help you in properly addressing this matter for this product. This

product may be recycled if unused, or if it has not been contaminated so as to make it unsuitable for its intended use.

If it has been contaminated, it may be possible to reclaim the product by filtration, distillation or some other means. If

neither of these options is suitable, consider controlled incineration, or landfill.

Section 14 - Transport Information

ADG Code:

This product is not classified as a Dangerous Good. No special transport conditions are necessary

unless required by other regulations.

Section 15 - Regulatory Information

AICS:

All of the significant ingredients in this formulation are compliant with NICNAS regulations.

Section 16 - Other Information

This MSDS contains only safety-related information. For other data see product literature.

Acronyms:

ADG Code

Australian Code for the Transport of Dangerous Goods by Road and Rail, 7th Edition

AICS

Australian Inventory of Chemical Substances

SWA

Safe Work Australia, formerly ASCC and NOHSC

CAS number

Chemical Abstracts Service Registry Number

IARC

International Agency for Research on Cancer

NTP

National Toxicology Program (USA)

R-Phrase

Risk Phrase

SUSMP

Standard for the Uniform Scheduling of Medicines & Poisons

UN Number

United Nations Number

Contact Points:

Pfizer

1800 814 883

Police and Fire Brigade:

Dial 000

If ineffective:

Dial Poisons Information Centre

(

13 1126 from anywhere in Australia)

Please read all labels carefully before using product.

This MSDS copyright © Kilford & Kilford Pty Ltd, August, 2011.

http://www.kilford.com.au/ Phone (02)9251 4532

MSDS18-VERSION1

Similar products

Search alerts related to this product

View documents history

Share this information